Iradimed Financial Overview
Iradimed's market cap is currently $1.22B. The company's EPS TTM is $0.47; its P/E ratio is 58.30; and it has a dividend yield of 0.72%. Iradimed is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $0.48. See an overview of income statement, balance sheet, and cash flow financials.
